On tour for CAHO’s visit to Lawson. From left: Dr. Gillian Kernaghan, President & CEO, St. Joseph’s; Murray Glendining, President & CEO, LHSC; MPP Jeff Yurek; MP Karen Vecchio; Karen Michell, Executive Director, CAHO; Dr. David Hill, Scientific Director, Lawson.
Dr. Glenn Bauman, Chair/Chief Department of Oncology, Lawson Scientist and Radiation Oncologist at LHSC, explains why enrollment in clinical trials is so important.
“Clinical trials generate the evidence we need to improve the care of our patients. They bring knowledge from the laboratory to care in the clinic.”
Starting February 3, you may see staff members and physicians at London Health Sciences Centre (LHSC) and St. Joseph’s Health Care London (St. Joseph’s) wearing “Ask me about clinical trials” buttons.
From left: Dr. Trevor Shepherd, Peter and Trudy Channer, Sheila Fletcher, Dr. Gabriel DiMattia, (back row) the Pooley Family (not pictured: Robert Freeland and George Monckton)
A small group of generous individuals donated $200,000 toward cutting-edge technology that’s significantly improved the capabilities of the Translational Ovarian Cancer Research Team at Lawson Health Research Institute.
The IncuCyte Zoom is able to analyze the growth of dozens of patient cancer cells, outputting the data to create an accurate and real-time visual of tumour cell growth, while simultaneously allowing for an environment to test and monitor different treatments on cells.